In the semaglutide group, the number of zero heavy drinking days increased significantly from weeks 1 through 8
Currently, no large-scale clinical trials have established a direct link between semaglutide and memory impairment, and memory loss is not listed as a recognised side effect by the MHRA
In vivo: Male Flinders Sensitive Line (FSL) rats and male CD1 mice, exposed to model genetic and environmentally induced depression, respectively, were injected intraperitoneally with ALCAR 100 mg/kg for 21 days
Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency
US guidelines suggest limiting alcohol to 2 drinks/day for men and 1 drink/day for women, with abstinence advised for those with liver disease
Care goals: clarify glucose, weight, tolerability, nutrition, and quality-of-life priorities